ArticleThe European respiratory journal2026

Decreased pulmonary exacerbations and lower intravenous antibiotic usage following vanzacaftor/tezacaftor/deutivacaftor treatment in people with cystic fibrosis with

Alexander Horsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.